These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36851131)

  • 1. Evolution of Tick Vaccinology Highlights Changes in Paradigms in This Research Area.
    Estrada-Peña A; Fuente J
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inspiring Anti-Tick Vaccine Research, Development and Deployment in Tropical Africa for the Control of Cattle Ticks: Review and Insights.
    Kasaija PD; Contreras M; Kirunda H; Nanteza A; Kabi F; Mugerwa S; de la Fuente J
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for new and improved vaccines against ticks and tick-borne diseases.
    de la Fuente J; Kopáček P; Lew-Tabor A; Maritz-Olivier C
    Parasite Immunol; 2016 Dec; 38(12):754-769. PubMed ID: 27203187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of vaccines against Ornithodoros soft ticks: An update.
    Díaz-Martín V; Manzano-Román R; Obolo-Mvoulouga P; Oleaga A; Pérez-Sánchez R
    Ticks Tick Borne Dis; 2015 Apr; 6(3):211-20. PubMed ID: 25802033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational biotechnology for the control of ticks and tick-borne diseases.
    de la Fuente J
    Ticks Tick Borne Dis; 2021 Sep; 12(5):101738. PubMed ID: 34023540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the identification and characterization of protective antigens for recombinant vaccines against tick infestations.
    de la Fuente J; Kocan KM
    Expert Rev Vaccines; 2003 Aug; 2(4):583-93. PubMed ID: 14711342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with Recombinant Subolesin Antigens Provides Cross-Tick Species Protection in
    Kasaija PD; Contreras M; Kabi F; Mugerwa S; de la Fuente J
    Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32570925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference screening in ticks for identification of protective antigens.
    de la Fuente J; Almazán C; Blouin EF; Naranjo V; Kocan KM
    Parasitol Res; 2005 Jun; 96(3):137-41. PubMed ID: 15824899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of reverse vaccinology approaches for the development of vaccines against ticks and tick borne diseases.
    Lew-Tabor AE; Rodriguez Valle M
    Ticks Tick Borne Dis; 2016 Jun; 7(4):573-85. PubMed ID: 26723274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinomics, the new road to tick vaccines.
    de la Fuente J; Merino O
    Vaccine; 2013 Dec; 31(50):5923-9. PubMed ID: 24396872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Tick Vaccines: Current Advances and Future Prospects.
    Muhanguzi D; Ndekezi C; Nkamwesiga J; Kalayou S; Ochwo S; Vuyani M; Kimuda MP
    Methods Mol Biol; 2022; 2411():253-267. PubMed ID: 34816410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tick vaccines: current status and future directions.
    de la Fuente J; Contreras M
    Expert Rev Vaccines; 2015; 14(10):1367-76. PubMed ID: 26289976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of tick infestations and pathogen prevalence in cattle and sheep farms vaccinated with the recombinant Subolesin-Major Surface Protein 1a chimeric antigen.
    Torina A; Moreno-Cid JA; Blanda V; Fernández de Mera IG; de la Lastra JM; Scimeca S; Blanda M; Scariano ME; Briganò S; Disclafani R; Piazza A; Vicente J; Gortázar C; Caracappa S; Lelli RC; de la Fuente J
    Parasit Vectors; 2014 Jan; 7():10. PubMed ID: 24398155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tick vaccines and the transmission of tick-borne pathogens.
    de la Fuente J; Kocan KM; Blouin EF
    Vet Res Commun; 2007 Aug; 31 Suppl 1():85-90. PubMed ID: 17682852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling tick vaccines: a key tool to improve protection efficacy.
    de la Fuente J; Estrada-Peña A; Contreras M
    Expert Rev Vaccines; 2020 Mar; 19(3):217-225. PubMed ID: 32192377
    [No Abstract]   [Full Text] [Related]  

  • 16. A Roadmap for Tick-Borne Flavivirus Research in the "Omics" Era.
    Grabowski JM; Hill CA
    Front Cell Infect Microbiol; 2017; 7():519. PubMed ID: 29312896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Vaccinomics Approach for the Identification of Tick Protective Antigens for the Control of
    Contreras M; Villar M; de la Fuente J
    Front Physiol; 2019; 10():977. PubMed ID: 31417430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticks and antibodies: May parasite density and tick evasion influence the outcomes following immunization protocols?
    Ferreira Leal B; Sanchez Ferreira CA
    Vet Parasitol; 2021 Dec; 300():109610. PubMed ID: 34735848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying proteomics to tick vaccine development: where are we?
    Villar M; Marina A; de la Fuente J
    Expert Rev Proteomics; 2017 Mar; 14(3):211-221. PubMed ID: 28099817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting a global health problem: Vaccine design and challenges for the control of tick-borne diseases.
    de la Fuente J; Contreras M; Estrada-Peña A; Cabezas-Cruz A
    Vaccine; 2017 Sep; 35(38):5089-5094. PubMed ID: 28780117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.